Manufacturer: Clinic Consults and Tests

The Estronex™ 2/16 Test from Metametrix Clinical Laboratory measures the ratio of these two critical estrogen metabolites from a single urine specimen. Estronex 2/16 ratios less than 2.0 indicate increasing long-term risk for breast, cervical, and other estrogen-sensitive cancers. Importantly, nutritional interventions can help raise Estronex 2/16 ratios and decrease long-term risk. A simple first-morning urine specimen, no blood draw is necessary. You collect urine at home, and receive a copy of the results.